- Investing Ideas
- /
- U.S. Healthcare Undervalued Stocks Based On Cash Flows
U.S. Healthcare Undervalued Stocks Based On Cash Flows
Results
9
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
9 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LFMD | US$4.95 | -6.8% | -6.3% | US$214.4m | US$12.00 | PS1.1x | E111.2% | n/a | ||
HQY | US$96.81 | -0.6% | 41.2% | US$8.3b | US$113.00 | PE86.8x | E39.6% | n/a | ||
SLP | US$27.91 | -3.0% | -32.0% | US$559.7m | US$50.00 | PE56.3x | E30.5% | 0% | ||
DXCM | US$78.50 | -2.6% | -35.6% | US$30.4b | US$96.26 | PE45x | E16.1% | n/a | ||
PNTG | US$26.46 | -2.3% | 86.9% | US$910.9m | US$37.20 | PE43x | E30.0% | n/a | ||
ZYXI | US$7.81 | -6.1% | -27.7% | US$255.1m | US$17.50 | PE51.6x | E38.8% | n/a | ||
IRTC New | US$89.44 | -0.6% | -10.8% | US$2.8b | US$105.58 | PS5x | E63.5% | n/a | ||
INSP | US$189.19 | 0.05% | 9.2% | US$5.6b | US$239.60 | PE171.6x | E31.3% | n/a | ||
AORT | US$28.08 | -4.3% | 62.3% | US$1.2b | US$33.17 | PS3.1x | E123.9% | 0% |
Page 1 of 1